Linking oncogenesis and immune system evasion in acquired resistance to EGFR-targeting antibodies: Lessons from a preclinical model

por Garrido, Greta, Rabasa, Ailem, Sánchez, Belinda
Publicado 2013

EGFR-Targeting as a Biological Therapy: Understanding Nimotuzumab's Clinical Effects

por Perez, Rolando, Moreno, Ernesto, Garrido, Greta, Crombet, Tania
Publicado 2011

Upregulation of HLA Class I Expression on Tumor Cells by the Anti-EGFR Antibody Nimotuzumab

por Garrido, Greta, Rabasa, Ailem, Garrido, Cristina, Chao, Lisset, Garrido, Federico, García-Lora, Ángel M., Sánchez-Ramírez, Belinda
Publicado 2017

Tumor-targeted silencing of the peptide transporter TAP induces potent antitumor immunity

por Garrido, Greta, Schrand, Brett, Rabasa, Ailem, Levay, Agata, D’Eramo, Francesca, Berezhnoy, Alexey, Modi, Shrey, Gefen, Tal, Marijt, Koen, Doorduijn, Elien, Dudeja, Vikas, van Hall, Thorbald, Gilboa, Eli
Publicado 2019